Status:
COMPLETED
Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer
Lead Sponsor:
Gunma University
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
8-2 years
Brief Summary
Objective: L-\[3-18F\]-α-methyltyrosine (FMT) is an amino-acid tracer for PET. We evaluated the diagnostic usefulness of 18F-FMT PET in non-small cell lung cancer (NSCLC) patients. Tumor uptake of 18F...
Eligibility Criteria
Inclusion
- proven or suspected non-small cell lung cancer
Exclusion
- uncontrolled diabetes mellitus
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00464282
Last Update
April 23 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.